CD274 and neoplasm: Incorporating biomarkers such as PD-L1 expression levels, tumor mutational burden (TMB), microsatellite instability (MSI), and immune cell infiltration scores into the nomogram could significantly refine its predictive accuracy for LAUEC patients.